SynthesisFrontiers in oncology2025

Predicting overall survival benefit in previously untreated, unresectable or metastatic melanoma from improvement in progression-free survival: a correlation meta-analysis.

Peter Mohr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.